FEED ENvue Medical, Inc.
Healthcare$1.01+8.60%ClosedMarket Cap: $1.1M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.10
P/S
0.51
EV/EBITDA
-0.00
DCF Value
$-93.28
FCF Yield
-1117.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
-12.4%
Operating Margin
-623.3%
Net Margin
-744.2%
ROE
-43.7%
ROA
-40.7%
ROIC
-39.2%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $653.0K | $-3.8M | $— |
| Q4 null | $312.0K | $-12.9M | $— |
| FY null | $2.6M | $-18.2M | $— |
| Q3 null | $722.0K | $600.0K | $— |
Analyst Ratings
View AllConsensus
—
Target (Consensus)
$4.65
Target (Median)
$4.65
Target Range
$4.65 - $4.65
0 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell
Trading Activity
Insider Trades
View AllGlibert Christian Michaelother: No longer a 10% holder
SellFri Apr 17
Fernandez-McGovern Nicole M.officer
SellThu Feb 26
Glibert Christian Michael10 percent owner
BuyWed Feb 11
Glibert Christian Michael10 percent owner
SellWed Feb 11
BANK OF AMERICA CORP /DE/10 percent owner
SellThu Feb 05
Company Info
Sector
Healthcare
Industry
Medical - Specialties
Country
US
Exchange
—
Beta
1.59
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.